MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
New board reflects company’s added focus on oncology & autoimmune diseases SARASOTA, Fla. and MIAMI, Feb. 19, 2025 (GLOBE ...
NAYA Biosciences (NAYA) announced that its board of directors has nominated five new candidates with extensive experience in in the ...
After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM's president of precision fermentation and ADM ...
The most scalable and high-resolution single cell solution available SEATTLE--BUSINESS WIRE--Parse Biosciences, the leader in high-throughput single ...
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib ...
Today’s Forbes Daily newsletter covers Colossal Biosciences' plan to bring back the wooly mammoth, Apple’s new iPhone 16e, IRS job cuts, Palantir’s stock drop and more.
The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.
U.S. stock futures fell on Wednesday after scaling fresh records on Tuesday. The futures of all four benchmark indices were ...